Pharmasset, Inc. Company Profile
We are a clinical-stage pharmaceutical company committed to discovering, developing and commercializing novel drugs to treat viral infections. Our primary focus is on the development of oral therapeutics for the treatment of human immunodeficiency virus, or HIV, hepatitis B virus, or HBV, and hepatitis C virus, or HCV. Our research and development efforts focus on a class of compounds known as nucleoside analogs, which act to inhibit the natural enzymes required for viral replication.
303-A College Road East
United States of America
Phone: (609) 613-4100
Fax: (609) 613-4150
Summary Pharmasset, Inc. (Pharmasset.) is a health care pharmaceutical company. The company is engaged in discovering, producing and commercializing medicines to treat viral infections. The company fo...
Pharmasset announce promising results for experimental Hepatitis C therapy
Recently added to the BioPortfolio report store, Pharmasset, Inc (VRUS) - Pharmaceuticals & Healthcare - Deals and Alliances Profile is a new report from GlobalData published on 2014-11-16. This ...
In Reply Dr Lopert and Mr Welch and Dr Green make the point that the Gilead purchase of Pharmasset does not accurately reflect the true costs of development of sofosbuvir. We agree.
A look at today's forthcoming news stories: Sales up but profits down for Pfizer and Merck & Co after mega-mergers; disappointment for Dainippon as epilepsy drug fails to win approval, and US drug dev...
Tekmira Pharmaceuticals Corp. (TSX:TKM; NASDAQ:TKMR) surged $8.98 (57%) to $24.68 on Monday after announcing plans to merge with OnCore Biopharma Inc. (Doylestown, Pa.). Under the proposed merger, OnC...
HBV play OnCore Biopharma Inc. (Doylestown, Pa.) acquired infectious disease company Enantigen Therapeutics Inc. (Doylestown, Pa.) in an all-cash deal of undisclosed size. OnCore gains two HBV program...
Drugs and Medications
We are a clinical-stage pharmaceutical company committed to discovering, developing and commercializing novel drugs to treat viral infections. Our primary focus is on the development of oral therapeut...
More Information about "Pharmasset, Inc." on BioPortfolio
We have published hundreds of Pharmasset, Inc. news stories on BioPortfolio along with dozens of Pharmasset, Inc. Clinical Trials and PubMed Articles about Pharmasset, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Pharmasset, Inc. Companies in our database. You can also find out about relevant Pharmasset, Inc. Drugs and Medications on this site too.